Related Experiment Video
Updated: May 22, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Functional genomic methods to study estrogen receptor activity
Siv Gilfillan1, Elisa Fiorito, Antoni Hurtado
1Breast Cancer Research group, Nordic EMBL Partnership, Centre for Molecular Medicine Norway, University of Oslo, Blindern, Oslo, Norway.
Abstract:
Estrogen Receptor (ER) is a nuclear receptor that mediates the actions of estrogen and tamoxifen. ER is expressed in a major fraction of human breast cancers. Recently, genomic maps for estrogen- and tamoxifen-ER have been published. Interestingly, estrogen and tamoxifen induce similar genomic interactions and both ligands have been shown to use co-operating factors. The interactions of these co-operating factors within ER regions have impact both on ER-DNA interactions and gene expression regulated by estrogen and tamoxifen. Moreover, the study of chromatin changes induced by these factors has also provided significant insight into our understanding of ER transcriptional regulation. This methods review describes some functional genomic methods to study the influence of both ER ligands and ER co-operating factors. The analysis of protein-DNA interactions and chromatin changes can be explored by using classical and novel methods such as Chromatin Immunoprecipitation (ChIP) or Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE). This review also explores the properties of each of these methods and the advantages of combining them with high throughput sequencing.
Insights
Estrogen Receptor (ER) research reveals how estrogen and tamoxifen impact breast cancer genomics. Functional genomic methods like ChIP and FAIRE help analyze these ER-ligand interactions and chromatin changes.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- Estrogen Receptor (ER) is crucial in mediating estrogen and tamoxifen actions.
- ER is frequently expressed in human breast cancers.
- Genomic mapping of ER interactions with estrogen and tamoxifen has recently been established.
Purpose of the Study:
- To review functional genomic methods for studying ER ligand and co-operating factor influences.
- To explore methods analyzing protein-DNA interactions and chromatin modifications.
- To understand ER transcriptional regulation in breast cancer.
Main Methods:
- Chromatin Immunoprecipitation (ChIP) for protein-DNA interactions.
- Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE) for chromatin accessibility.
- Integration of these methods with high-throughput sequencing.
Main Results:
- Estrogen and tamoxifen induce similar genomic interactions via co-operating factors.
- These interactions affect ER-DNA binding and gene expression.
- Chromatin changes provide insights into ER transcriptional regulation.
Conclusions:
- Functional genomic methods are essential for dissecting ER-ligand and co-factor roles.
- Combining ChIP and FAIRE offers a comprehensive approach.
- Understanding these mechanisms advances breast cancer therapy insights.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Reporter Genes
Commonly used reporter...

